Weight-loss drug Belviq may increase cancer risk, FDA says
Weight-loss drug Belviq may increase cancer risk, FDA says

On Tuesday, the U.S. Food and Drug Administration announced that a weigh-loss drug may increase your risk of cancer.

Story: http://bit.ly/386TMpy